BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191022
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T022904
CREATED:20190806T094720Z
LAST-MODIFIED:20190806T094807Z
UID:21857-1571702400-1571961599@www.pharmajournalist.com
SUMMARY:Lab Asset & Facility Management In Pharma 2019
DESCRIPTION:The 2nd annual Lab Asset & Facility Management in Pharma summit is the only industry-led platform to join 120+ senior experts from Lab Operations\, Facility Management\, Lab Supplies and Procurement across pharma\, biotech\, CROs and research institutions. \n \nJoin your colleagues who are beginning to implement end-to-end asset management programs to optimize spend and gain better visibility of inventory and equipment lifecycles in order to maximize capital efficiency. \nAt the event\, you’ll delve into your core challenges\, including: \n\nHow to increase R&D productivity and avoid unnecessary downtime\nRevise the operating model for lab facility and asset supplies\nOptimize utilization of lab equipment and facility footprint\nExplore new technologies and IoT for asset monitoring and predictive maintenance\nExtend and manage your equipment lifecycle\nEvaluate your relationships and collaborations with OEMs\n\nDon’t miss out on this one of a kind meeting to engage with your peers and re-define best practice for tomorrow’s operations! \nTo learn more and to register online\, visit: https://ter.li/lafm-listing-home
URL:https://www.pharmajournalist.com/event/lab-asset-facility-management-in-pharma-2019/
LOCATION:The Westin San Diego\, 400 West Broadway\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191022
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T022904
CREATED:20190924T120933Z
LAST-MODIFIED:20190924T120933Z
UID:22557-1571702400-1571961599@www.pharmajournalist.com
SUMMARY:2nd Targeted Protein Degradation Summit
DESCRIPTION:Finally Drug the “Undruggable” Through Targeted Protein Degradation.  Encapsulating the excitement of the field of protein degradation; The 2nd TPD Summit 2019 is the definitive\, comprehensive and industry-dedicated conference for the field of protein degradation – focused on optimizing target validation\, improving medicinal chemistry & rational design and ultimately accelerating the translation of selective\, bioavailable and effective protein degraders into clinical trials. \nWith 50+ speakers\, 40+ late-breaking case studies\, 3 dedicated streams\, 6 technical deep-dives & 400+ attendees\, TPD 2019 is the most comprehensive and the definitive guide for large pharma\, innovative biotech and leading academic researchers to capitalize on this emerging therapeutic class and make targeted protein degradation a blockbuster therapeutic approach that improves patient outcomes. \nAs the previously untapped drug discovery opportunity promised within the proteome becomes a reality and “undruggable” targets are finally being reached\, the field of targeted protein degradation is truly changing the face of small molecule drug discovery. In the pursuit to demonstrate safe and effective clinical results\, it’s clear that a set of unique development challenges must be overcome for these novel therapeutics to achieve their seemingly limitless potential. \nView the program and speaker list here: https://ter.li/idctdn
URL:https://www.pharmajournalist.com/event/2nd-targeted-protein-degradation-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Drive\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T022904
CREATED:20170510T082131Z
LAST-MODIFIED:20190514T085314Z
UID:1755-1571788800-1571961599@www.pharmajournalist.com
SUMMARY:SAPHEX 2019
DESCRIPTION:SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre\, Johannesburg\, South Africa. \n \nSAPHEX serves a primary platform for both local and international companies working in the South African or Africa pharmaceutical manufacturing industry. The exhibition brings together key visiting pharma suppliers and buyers\, with a range of exhibitors from across the pharmaceutical sector. \nDon’t miss out on your chance to participate at this event. \nTo learn more about this event and to register online\, visit www.saphex.co.za \n 
URL:https://www.pharmajournalist.com/event/saphex/
LOCATION:GALLAGHER CONVENTION CENTRE\, 10 RICHARDS DRIVE\, HALFWAY HOUSE\, MIDRAND\, 1685\, South Africa
ORGANIZER;CN="SAPHEX":MAILTO:jessica@saphex.co.za
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191025
DTSTAMP:20260515T022904
CREATED:20180620T145021Z
LAST-MODIFIED:20190521T094434Z
UID:16375-1571788800-1571961599@www.pharmajournalist.com
SUMMARY:Lyophilization USA
DESCRIPTION:SMi Presents the 5th annual\nLyophilization USA Conference\nDate: October 23-24\, 2019\nWorkshop: October 25\, 2019\nLocation: Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, USA\nWebsite: www.lyophilisation-usa.com/PJBan \nAbout Lyophilization USA \nThe SMi Group is pleased to invite you to the 5th Annual Lyophilization USA Conference arranged to take place on the 23rd and 24th October 2019\, in Boston. \n \nThe current list of FDA-approved biopharmaceuticals contains up to 50% of injectables and approximately a third of all parenterals being lyophilized\, which suggests it is the optimal way of ensuring stability in products that are unstable in aqueous solution. This instability or degradation can result in suboptimal product performance and even toxicity in worst cases indicating the need for lyophilization despite it’s inherently expensive running costs and time-consuming process. \nJoin us this year to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of lyophilization. Benchmark and network with industry leaders and discuss the most up to date and relevant topics that delve into alternative lyophilization approaches\, applied statistical modelling\, fresh views on scaling up and tech transfer\, pre- and post-product characterization. regulation and beyond. \nDISCUSSION HIGHLIGHTS: \nGain valuable insight into the most current challenges and considerations when working with highly concentrated and sensitive formulations \nExplore new and innovative approaches in model-based studies that utilise the power of statistical analysis to improve process development and understanding \nDiscuss the future outlook of lyophilization through trends in alternative approaches \nDiscover updates on the leading PAT technologies such as controlled nucleation\, continuous freeze drying\, low-frequency Raman\, vacuum-foam drying and more. \nListen to key opinion leaders and experts from regulatory bodies speak about expectations and the assessment of reliable technologies in the market \nView the full agenda: www.lyophilisation-usa.com/PJBan \nContact Info:\nT: +44 (0) 20 7827 6164\nE: nhoward@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/lyophilization-usa-2019/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
ORGANIZER;CN="SMi Group Ltd":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191026
DTSTAMP:20260515T022904
CREATED:20180725T131813Z
LAST-MODIFIED:20190717T090554Z
UID:16872-1571788800-1572047999@www.pharmajournalist.com
SUMMARY:3rd Annual NASH Summit Europe 2019
DESCRIPTION:Welcome to Europe’s Gathering of NASH Drug Developers: The 3rd NASH Summit Europe\n\nDeepen Understanding of the Role of Liver Fibrosis in NASH\nConfidently Meet Regulatory Guidelines\nDefine Clinical Trial Endpoints\n\n \nReturning as the only NASH forum exclusively facilitating industry-to-industry dialogue and collaboration in Europe; the 3rd NASH Summit Europe will once again showcase leading data and leverage expert insights to advance pipeline success in NASH. \n“The NASH Summit was unlike any scientific meeting I have ever been to.  Everyone who attended was interested in some aspect of drug development for NASH.  I truly enjoyed the “applied science” focus of the meeting as it helped me where I most needed the help.  The opportunity to network and learn informally in the poster session and during receptions was excellent.”\nEli Lilly \nSee & hear from the 3rd NASH Summit Boston attendees to better understand how the NASH Summit is uniquely dedicated to advancing the therapeutic potential of NASH therapeutic \nTo learn more about this event\, and to register online\, visit https://nash-europe.com/ \nContact:\nPhone – +44 (0)20 3141 8700\nEmail – info@hansonwade.com
URL:https://www.pharmajournalist.com/event/nash-summit-europe/
LOCATION:The Waldorf Hilton\, London\, Aldwych\, London\, WC2B 4DD\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191026
DTSTAMP:20260515T022904
CREATED:20190712T103804Z
LAST-MODIFIED:20190712T104710Z
UID:21568-1571788800-1572047999@www.pharmajournalist.com
SUMMARY:Neuromuscular Drug Development Summit (NMD)
DESCRIPTION:Now in its 2nd year\, the industry-focused NMD Summit will overcome the challenges preventing neuromuscular drug developers bringing truly transformative therapeutics to market. \nWith an emphasis on ALS\, SMA\, DMD and other rare diseases\, 18 expert speakers from the likes of Biogen\, Audentes and PTC Therapeutics will share their insights across 3 packed days. \nJoin 90+ neuromuscular stakeholders at this definitive forum to exchange novel ideas\, gather lessons learned and establish new collaborations. \nTo learn more about this event\, and to register online\, visit https://ter.li/bgvvh7
URL:https://www.pharmajournalist.com/event/neuromuscular-drug-development-summit-nmd/
LOCATION:The Westin Boston Waterfront\, 425 Summer Street\, Boston\, Massachusetts\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191026
DTSTAMP:20260515T022904
CREATED:20190827T091030Z
LAST-MODIFIED:20190827T091030Z
UID:22138-1571788800-1572047999@www.pharmajournalist.com
SUMMARY:BioNetwork 2019
DESCRIPTION:BioNetwork\nOctober 23 – 25\, 2019\nThe Ritz-Carlton Laguna Niguel\, CA \nFor the past 15 years\, BioNetwork has brought together the most senior-level decision makers in pharma and biotech deal-making (CEOs of BioTechs\, VPs of BD from Big Pharma). Meet the right people and create the ideal partnerships. \n \nDiscount Code: BN19PJ \nTo learn more about BioNetwork 2019 and to register online\, visit http://bit.ly/2ZnZSRN
URL:https://www.pharmajournalist.com/event/bionetwork-2019/
LOCATION:The Ritz-Carlton Laguna Niguel\, CA
ORGANIZER;CN="Worldwide Business Research":MAILTO:Cynthia.Liu@wbresearch.com
END:VEVENT
END:VCALENDAR